Health

STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 06/10/2026, 14:37:24 UTC.

Briefings

Utah regulators approved an AI pilot for acne treatment and prescription writing by Nolla Health, allowing the startup to evaluate patients and select low-risk drugs without prior human review in the first stages. The pilot is part of Utah's expanded AI sandbox program, which waives medical regulations for testing under state supervision. Nolla raised $4.5 million last year and aims to treat various conditions using AI, with the new pilot representing a significant expansion of its capabilities.

Key points

• Nolla Health launched an AI service in Utah to evaluate patients for mild-to-moderate acne using photos and analyze skin conditions.
• The AI may determine if low-risk drugs are appropriate for treatment, with the first stage requiring a licensed clinician to review and sign off on prescriptions.

Context

This finding matters as it represents a significant expansion of Utah's AI sandbox program, allowing companies to test AI products under state supervision while waiving certain medical regulations. Nolla Health raised $4.5 million last year and aims to direct treatment for a host of conditions using AI.

Limitations

Evidence is limited to the initial announcement of the pilot; the full scope of the program and future regulatory changes remain unknown. The evidence does not include specific dates for the AI's operational launch or the full timeline of the pilot's phases.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 21/10/2026, 10:50:59 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeighk6nqbezv2ytovdyok7y3tb2knynlytehqvwttdln76owt2ljoy